Glucagon-like peptides - Open Access .click

Results 101 to 110 of about 42,175 (206)

Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives

Acta Pharmaceutica Sinica B
Diabetes, characterized by hyperglycemia, is a major cause of death and disability worldwide. Peptides, such as insulin and glucagon-like peptide-1 (GLP-1) analogs, have shown promise as treatments for diabetes due to their ability to mimic or enhance ...
Bingwen Ding +5 more
doaj +1 more source

Discovery, characterization, and clinical development of the glucagon-like peptides. [PDF]

J Clin Invest, 2017
Drucker DJ, Habener JF, Holst JJ.
europepmc +1 more source

Bioactive Peptides from Sodium Caseinate Hydrolysate with High Oral Absorption Regulate Blood Glucose in Type 2 Diabetic Mice via Inhibition of DPP-IV and Stimulation of GLP-1

Foods
Type 2 diabetes mellitus remains a critical global health challenge, driving the pursuit of novel therapeutic strategies. This study investigated the anti-diabetic efficacy of the peptide 1CBR, derived from sodium caseinate hydrolysate, administered ...
Pei-Yu Wu +7 more
doaj +1 more source

The glucagon-like Peptide-2

, 2011
Multiple peptide hormones produced within the gastrointestinal system act also in the central nervous system and aid in the regulation of energy homeostasis and metabolism. The list of these peptides is progressively increasing and includes glucagon-like peptide 2 (GLP-2) as an anorexigenic factor.
openaire +2 more sources

Glucagon-like peptide 1 [PDF]